Latest National Institute for Health and Clinical Excellence Stories

2006-08-21 03:00:43

LONDON (Reuters) - Two new targeted therapies for bowel cancer should not be used on Britain's state-run health service, the country's cost-effectiveness watchdog NICE said on Monday. The recommendation angered patient groups, since both Avastin and Erbitux are widely available in the United States and much of Europe. The National Institute for Health and Clinical Excellence (NICE), however, decided the high cost of the medicines meant their use was not "compatible with the best use...

2005-06-14 18:45:14

Health professionals led by a cancer specialist from the University of Edinburgh have put forward the case for finding new and fairer ways to assess the value of treatments for patients who will eventually die from their condition. Writing in the current edition of the British Medical Journal (10 June, 2005) the experts argue that this issue should be explored because of its impact on national decisions about which new treatments are funded. Lead author of the BMJ article, Dr Ross Camidge,...

Word of the Day
  • A vial or small glass bottle, especially one for holding vinegar, oil, etc.; a caster for liquids.
This word is Middle English in origin, and ultimately comes from the Old French, diminutive of 'crue,' flask.